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Dedication
My DNP Practice Improvement Project is dedicated to all patients who benefit from
recommended screenings in the primary care setting. As a result of this project, I have a heightened
awareness for various screening needs and the understanding that primary providers must be the
catalyst to ensure patients receive recommended screenings.
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Abstract
Purpose: The purpose of this study was to evaluate primary care provider screening for
hepatitis C virus (HCV) in three high risk populations. The specific aims were to determine the
percentage of patients born between 1945-1965 who had a one-time screening for HCV, to
determine what proportion of patients with a history of human immunodeficiency virus (HIV) or
intravenous drug use (IVDU) have been screened for HCV, and to examine providers’ thoughts
on their HCV screening practices.
Methods: A retrospective chart review of patient electronic medical records (EMR’s) from
2015 was conducted in an urban primary care site. SPSS was used to analyze the data. A
provider survey was conducted to assess comfort, familiarity, and adherence with screening
recommendations.
Results: The sample demographics were very similar to the total population of the practice. Of
the birth cohort, it was determined that 6.1% were screened per the USPSTF recommendations.
The HIV positive and IVDU groups were very small and either were not screened at all or were
screened by a specialist. Of the individuals screened, 16.7% were positive for HCV. The
provider survey demonstrated belief that screenings were done per recommendations. Barriers to
screening according to the recommended guidelines included coding and insurance denials for
screenings. The provider survey suggested acknowledged an EMR trigger would assist in
prompting more screenings.
Conclusion: The study demonstrates there is opportunity to improve screening rates of the birth
cohort. There is insufficient evidence to determine if there are gaps in screening HIV and IVDU.
Future studies should focus on additional high risk groups with larger sample sizes.
Keywords: HCV, screening, recommendations

EVALUATING HEPATITIS C SCREENING IN PRIMARY CARE

2

Evaluating Hepatitis C Screening in Primary Care
Introduction
The World Health Organization (2014) estimates that over 180 million people worldwide
have been infected with the hepatitis C virus (HCV). The disease is the most common bloodborne infection in the United States (U.S.; Armstrong et al., 2006). Affecting approximately 2.73.9 million Americans, HCV represents 1.8% of the population (Centers for Disease Control and
Prevention [CDC], 2014). Further estimates suggest that two-thirds of all HCV infections are
found in individuals born between the years of 1945-1965 (Institute of Medicine [IOM], 2010).
These persons have been given the description the “birth cohort” by researchers who have
recognized the significance of the disease burden facing this population. The CDC (2013) and
the United States Preventative Services Task Force (USPSTF; 2013) recognize the heightened
risk facing the birth cohort and have both issued moderate to strong recommendations for
providers to perform a one-time antibody screening to assist in identification of HCV. These
recommendations were born of the realization that HCV can go for decades without producing
obvious signs of illness, yet it can silently cause irreversible liver damage. Further, research has
demonstrated up to 75% of those infected were unaware of their disease state (Southern et al.,
2011).
Chronic HCV results in a slow progressive inflammatory response causing liver fibrosis
and hepatic infrastructure deterioration. As fibrosis worsens, the patient becomes at risk for
cirrhosis, hepatocellular carcinoma and a host of hepatic related complications that may take
decades to evolve (CDC, 2012). HCV leads to a number of chronic health conditions,
unexpected medical costs, disability, decline in quality of life, and in many cases death
(USPSTF, 2013). HCV was estimated to generate U.S. healthcare costs in excess of $6.5 billion

EVALUATING HEPATITIS C SCREENING IN PRIMARY CARE

3

in 2012, with further estimates that the burden of cost will peak in the year 2024 at an annual
$9.1 billion dollars (Razavi et al., 2013). Over the past decade, use of direct acting antivirals has
produced strong evidence that morbidity and mortality associated with HCV can be controlled
(Thomas, 2013). Successful treatment leading to a sustained virological response (SVR), has
recently gained significant strides in clearing the host of the virus entirely. Lack of knowledge
of infection status is the number one impediment to reduced transmission and treatment of HCV.
The CDC model of risk-based screening estimated that the U.S. birth cohort testing would reveal
over a million new cases of chronic HCV, opening the opportunity to treat the disease, improve
quality of life, reduce deaths, and lower the costs associated with the virus (Rein et al., 2011).
Despite the evidence-based guidelines released by the American Association for the
Study of Liver Diseases (AASLD) in conjunction with the Infectious Diseases Society of
America (IDSA; 2014) and supported by recommendations from the CDC and USPSTF, recent
studies show that primary care providers have low efficacy in HCV cohort screening rates
(Southern et al., 2011). A study performed in New York City assessed the screening practices of
three large primary care clinics and found an overall adherence rate of 36.1%. Another five-year
screening study, observing primary care providers in Maryland, Virginia, and the District of
Columbia, found the high risk birth cohort were screened at a rate of 14.4% (Linas, Hu, Barter,
& Horberg, 2014).
The CDC (2013) reported that the state of Kentucky’s statistics for new cases of HCV
increased by 357% between the years of 2007 and 2011 and in 2013 the state had the largest
number of new HCV cases in the nation (CDC, 2013). One leading health system (2015) is a
prominent provider of inpatient and outpatient health services serving a large portion of
Kentucky and the surrounding areas. The primary care medical group focuses on preventative
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medicine with an emphasis on maintaining wellness. Primary care providers had over 480,000
outpatient encounters in 2015 (Norton Healthcare Report to Our Community, 2015).
Objectives
Purpose of the Project
Taking into account the background and importance of HCV screening practices for
identification and treatment of active disease, a retrospective study was planned to examine
screening of the birth cohort and other high risk groups in one of the health systems primary care
practices. The aim of the study was to evaluate primary care provider screening practices and
survey providers’ perceptions of HCV testing related to compliance with current
recommendations.
Clinical Questions
In a primary care setting, do providers follow the recommendations established by the
CDC and USPSTF for HCV screening in high risk groups? Do certain high risk factors
determine if HCV screening is considered with any higher degree of frequency? Do providers
ask questions that would determine high risk status? Do providers feel that there are barriers in
HCV screening? Do providers believe an electronic medical record (EMR) trigger would
improve their ability to screen the birth cohort? If providers note high risk behavior, do they
document having done so in the EMR?
Literature Review
The birth cohort is currently experiencing an increase in HCV associated mortality and
morbidity (Ward, 2013). As the birth cohort ages, if they are unaware of their infection status
and the disease is allowed to silently evolve, they will begin to suffer irreversible and devastating
health effects from liver fibrosis (Ly et al., 2012). The CDC, USPSTF, IDSA, AASLD, and the
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American College of Gastroenterology (ACG) have all recommended additional risk based HCV
screenings. The recommendations include screening anyone with a history of using intravenous
drugs (IVDU), as well as anyone who has received clotting factor concentrates produced before
1987, had a consistently elevated alanine aminotransferase (ALT), received blood transfusion or
organ transplant prior to 1992, infected with human immunodeficiency virus (HIV), received
long-term dialysis, or received a blood transfusion from someone who later tested positive for
HCV (Afdhal et al., 2013). The recommendations also include screening men who have sex with
men (MSM), children born to HCV positive mothers, and anyone with known exposure to needle
sticks, sharps, or mucosal contact with HCV-positive blood. For the purposes of this study, the
focus on HCV screening will be limited to individuals born between 1945-1965, HIV positive
individuals, and anyone with a history of IVDU.
Greenfield (2002) defines the purposes of a literature review as discovering gaps in
current knowledge, exposing opposing viewpoints, discovering applicable research methods, and
revealing inconsistencies and unanswered questions regarding the subject. The purpose of this
literature review was to identify relevant studies regarding primary care provider’s efficacy in
screening for HCV in three high risk populations. The databases that were searched included
Cochrane, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed,
EBSCOhost, National Guideline Clearinghouse, and UpToDate. The USPSTF and the CDC
websites were also referenced for relevant research and updated statistics. The searches were
conducted using the keywords “hepatitis C”, “HCV”, “chronic hepatitis C”, and “hep C” in
combination with the following phrases, “screening”, “primary care”, “diagnosis”,
“identification”, “barriers”, “recommendations”, “high risk”, and “guideline”. A goal of
including articles five years old or less was established. However, it was found that original
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research that is still being referenced was outside of this window and was included in the
evidence. Further inclusion criteria included published, peer-reviewed and evidence-based
research, recognized by accredited medical organizations. National and international agencies
including the World Health Organization (WHO), USPSTF, and CDC were utilized for their
guidelines and recommendations. Additional specialty groups, including the IDSA, AASLD,
and ACG were also used as expert recommendations and research findings. Exclusion criteria
included research conducted that focused greater than fifty percent of the study on treatment,
screening for HCV was not primary in study, screening for disease other than HCV also included
in research, study focus on HCV disease progression, focus on atypical subcultures not
representative of the U.S. population, and main focus on cost effectiveness. Once the articles
were appraised and duplicates removed, a total of thirty-one articles remained. Of these articles,
one was a meta-analysis, three were systematic reviews, four were clinical guidelines, twentyone were cohort studies, and two were expert opinion.
The literature review was focused on determining primary care provider screening of
HCV in pre-determined risk groups and identifying barriers research found limiting screening
practices. Overall the findings were consistent in concluding that HCV screening per the
recommendations is done less than fifty percent of the time. One study found that once an
intervention to improve screening rates among the birth cohort was implemented, identification
of new cases of HCV was significant versus any other risk based screening (Southern et al.,
2015). A study looking at the prevalence of HCV in a community-based health setting, found
that beyond the birth cohort the next strongest association with carrying HCV antibodies was a
history of injection drug use (Porter, Lusk, & Katz, 2014). Another study looked at four large
primary care settings to determine provider knowledge regarding the recommendations of which
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populations should be tested for HCV (Jewett et al., 2015). Six primary care providers were
interviewed regarding their knowledge and application of the recommendations. One of which
reported awareness of existence of guidelines, but lacked familiarity of the details. Several of
the primary care providers incorrectly stated content of the guidelines. Further investigation
found risk behavior assessments were not routinely performed due to a perceived lack of time
and discomfort with discussing situational risks. Some providers reported overall discomfort and
confusion in testing, and many did not test unless there were symptoms to suggest hepatic
dysfunction.
McGowan and Fried (2012) found patient HCV screening barriers included deferral of
testing due to lack of patient awareness of recommendations, economic fears due to lack of
insurance, social pressures and fear of stigmatization, underlying psychiatric disease, and
disregard for provider recommendations. After the birth cohort, the two populations with the
highest incidence of HCV disease are IVDU and those with HIV (CDC, 2015). The co-infection
rates of HIV and HCV are between 50-90% in the U.S. A study published in 2014 found that
individuals with history of IVDU were more likely to have been tested for HCV by their primary
care provider if the provider knew of a history of IVDU (Barocas et al., 2014). The study also
found that patients who had high risk behaviors were reluctant to initiate a conversation with
their provider due to fear of being negatively judged. However, the authors determined that if
the provider asked about high-risk behaviors with a non-judgmental approach, the result was an
increase in individuals tested.
Sidlow and Msaouel (2015), implemented a targeted intervention using the EMR to
trigger a reminder to perform a one-time HCV screening of the birth cohort if not previously
tested. Screening rates pre-implementation were found to be 11% or 851 out of 7,764 of the
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individuals eligible for HCV screening. Post-implementation of the EMR trigger screenings
were found to improve significantly, as 46% or 3012 out of 6,577 of eligible patients were
screened. The benefit of adding the technological aid yielded a 254% increase in screenings.
Throughout the appraisal of the evidence, one element was consistently repeated: there is
opportunity to improve the knowledge base of existing primary care providers and improve
screening rates among the at-risk populations.
In 2013 the CDC recognized Kentucky as having the highest number of new HCV cases
in the country. A more recent study to identify the most HCV and HIV vulnerable counties in
the U.S., found 25% of these counties are in Kentucky (Van Handel et al., 2016). During the
first six months of 2013, the Kentucky inpatient billing cost for HCV related care was over
$174,000,000 for 5,387 individuals (Kentucky Cabinet for Health and Family Services, 2014).
Razavi et al., (2013) estimated that current costs to the U.S. to care for HCV related illness are
between $6.4-$13.3 billion dollars annually with yearly increases and a peak expected in 2025.
While there have been studies regarding HCV screening of pregnant women and their children in
Kentucky, there has not been a study to examine primary care providers’ screening of other high
risk groups. The background and literature review support the need to determine if primary care
providers in Kentucky are screening high risk patients per the recommendations of the CDC and
USPSTF. This study will specifically address the screening rates of high risk groups by one
group of primary care providers affiliated with a large hospital system in Kentucky.
Methods
Study Permission
Permission for this study was first obtained from the Norton Healthcare Office of
Research Administration (NHORA) #16-N0066 and then the University of Kentucky’s
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Institutional Review Board (IRB) #16-0282-P1G. IRB approval for this DNP Final Project was
issued on May 6, 2016.
Study Demographics and Setting
The practice site was located in an urban location in Louisville, Kentucky. Provided by
the healthcare system the 2015 demographics for the practice were 85% Caucasian, 8% African
American, less than 1% Hispanic, 6% classified as unanswered or other, 45% were male, and
55% female. Of the adult individuals identified for the study, 1990 out of 4608 were born
between the birth cohort years of 1945-1965, four were HIV positive, and five admitted to
IVDU. Patients who had any of these three pre-determined risk factors were randomly selected
for retrospective analysis of their EMR. The study design was set to analyze 100 charts fitting
the search criteria. Cross-sectional data were collected on selected patient demographics. These
included age, gender, ethnicity, birth year, HIV status, IVDU history, and HCV screening
history. Provider notes were also evaluated to determine if additional interventions were
implemented at the time of the visit to suggest HCV screening or high risk behavior was
discussed. There were several medical doctors (MD) and one advanced practice nurse
practitioner (APRN) who worked at the practice during the time the data were collected. The
second portion of the study focused on the practice’s providers and took place during the
summer of 2016.
Inclusion and Exclusion Criteria
Inclusion criteria for the study included patients 18 years and older with one of the
following: born in the birth cohort years, ever IVDU, or HIV positive. Exclusion criteria
included pregnant women, patients previously diagnosed with HCV, patients born outside the
birth cohort years of 1945-1965, and no history of IVDU or HIV.
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Instruments Used
An Excel dataset was supplied by Norton Healthcare containing demographic data
allowing the PI (principal investigator) the ability to identify subjects in the three high risk
groups. A data collection tool in the form of a spreadsheet was created in a Microsoft Word
document by the PI. SPSS statistical software was downloaded from the University of
Kentucky. Statistical assistance from the University of Kentucky was provided by Dr. Amanda
Wiggins, who assisted in creating meaningful results of data.
Study Procedures
Medical records that met the inclusion criteria for the study were requested from the
healthcare organizations data support. All patient encounters taking place between January 1,
2015 and December 31, 2015 were requested in randomized order. The PI was then able to
identify targeted populations by using the Excel file built by the organization. There was no
active recruitment for participants for this portion of the study. Per a randomized computer
number generator, the number 10 was produced and further randomization was implemented by
pulling every 10th medical record to achieve the sample size of 100. The medical records chosen
for the sample were then de-identified by using a crosswalk table and unique identifications to
protect patient confidentiality. The data collection tool built for the study contained no patient
identifiers. Both the crosswalk table and the data collection tool with responses were stored on a
password protected H drive.
The second portion of the study was a survey given to providers which included six short
answer questions to determine providers’ level of comfort and familiarity in screening for HCV
in at risk populations. The PI presented each of the providers with a questionnaire and consent
form. Each provider was given a brief explanation of the purpose of the questionnaire and how
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the information they provided would be anonymously used in evaluating how primary care
providers screen for HCV. The questionnaires were separate from the consents and no
identifying information was observable on the questionnaires. The consents were stored in the
PI’s locked office safe and the questionnaires were loaded into the password protected and
encrypted Norton Healthcare H drive.
Data Analysis
The data collection tool developed by the PI included demographic and clinical data that
would later be separated into categorical variables. Demographics included gender, race, age,
and birth cohort status. Detailed clinical information included if they were HIV positive,
acknowledged IVDU, or were screened for HCV in 2015. A more detailed chart review was
required by the PI to determine if the provider offered HCV screening, but the patient declined or
if the provider placed a note in the record regarding discussion of high risk behaviors that could
place the patient at risk of having HCV. The PI also looked at HIV positive patients to
determine if the provider acknowledged the need to monitor for co-existing diseases or that the
patient was managed by another service. This was done by examining each provider note in
2015 for a given medical record and examining for details to answer the aforementioned
questions.
Once the data were collected, SPSS was used to create outputs to allow the PI to analyze
and interpret the results. A continuous variable was used to assess the sample’s age range, mean
and standard deviation (See Table 1). Frequency distributions were used to describe categorical
variables the sample population (See Table 2). It was determined that further software analysis
to assess for associations was not of value due to the low screening rates across the sample
population. The determination was made to observe the small population of screened patients to
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determine if there were any notable conclusions. The six that were screened were all female and
predominantly Caucasian.
Results
Sample Characteristics
One hundred charts that met the inclusion criteria were reviewed. The mean age of the
patients was determined to be 60.5 years, with a potential range of 36-71. The mean being
skewed to the right was determined to be due to 98% of the sample being of the birth cohort
status, making their ages between 50-70 years old at the time the data were created. The sample
was noted 39% male, closely representative of the entire office demographic. The sample was
found to be 90% Caucasian, 8% Black or African American, 1% Hispanic, and 1 % unanswered
or other. Again, the race distribution of the sample was closely representative of the total
demographic.
HCV Screening per USPSTF Recommendation
The largest part of the sample represented the birth cohort of patients born between 1945
and 1965. A one-time HCV screening for all people born during this time has been a grade B
recommendation since 2013 (USPSTF, 2013). The findings in the sample concluded that 6.1%
of the 98 patients in the birth cohort were screened per the recommendations. The patients who
were positive for HIV or had a history of IVDU, were not tested for HCV in the primary care
setting. There also lack of documentation of discussion regarding high risk behaviors and
exposures in these charts. There was one notation regarding a HIV positive patient being
monitored for HCV by their infectious disease provider.
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Additional Findings
Of the six patients that were screened all were women, one was African American and
five were Caucasian. Of the sample that was screened for HCV, one patient had positive HCV
antibodies. Of the entire sample, 23 were not asked if they ever participated in illicit drug use
including IVDU.
Provider Survey
The providers at one office location were surveyed with a short open-ended questionnaire
regarding their thoughts on HCV screening. One provider was willing to complete the survey.
Response included that they routinely screen patients the born between 1945-1965. They felt all
patients are screened for high risk behaviors, but are not always honest in their responses to the
provider, therefore limiting the provider’s ability to make appropriate recommendations. There
were also noted barriers in HCV screening that included denial for payment if the lab was coded
“screening” and the patient did not have Medicare. It was suggested that a meeting for all
providers explaining how to code the screenings would be helpful. It was also noted they did not
screen HIV positive patients for HCV, but acknowledged that they probably should. They stated
that all of their HIV positive patients report seeing a specialist in infectious disease to manage
their combination therapies. In answering whether they thought an EMR trigger would help
prompt in screening the birth cohort, the response was “yes it does, it started this summer.”
Discussion
The study outcomes regarding actual screenings of at risk patients demonstrated
significant gaps in provider practice. In 2013 the USPSTF and CDC updated their
recommendations to support expanding HCV screening practices in high risk populations. With
providers missing 93.9% of the screenings recommended for the birth cohort, there is evidence to
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suggest that alternative methods of alerting providers could be of benefit. There is also a need to
address the requirement of screening patients who have a history of IVDU. The 23% of the total
sample missing screening for substance abuse of any kind also represents an opportunity for
improvement to ensure that providers are capturing all history that could alert them to increased
risk factors and the need to screen. Accuracy of social history is essential to clinical decision
making. Overall provider education regarding the 2013 recommendations by the USPSTF and
CDC could assist in bringing awareness to which patients need screening for HCV. The provider
survey demonstrated that they felt they screened the birth cohort per the recommendation;
however, only one provider was willing to complete the survey.
Limitations
Study limitations included an inconsistent provider practice due to turn over. Providers
retired, left the country, switched to in-patient only, and changed practice locations during the
year of focus in the retrospective analysis. The sample size was likely limiting to the study. A
larger sample may have uncovered a greater frequency of testing. Analysis of the HIV positive
and IVDU population was limited due to single digit representation within the practice. The
providers’ limited exposure to HCV positive patients may have effected their judgement to
screen. Of the 4608 patients’ visits in 2015, only 17 were known to have HCV, and of those 12
were in birth cohort. After randomization only one of these known subjects appeared in the
sample and did account for the HCV positive case.
Further limitations occurred with the provider survey. In May of 2016, the healthcare
organization created a trigger in their EMR to alert providers that the patient needed HCV
screening due to birth cohort status. The provider survey, previously created without knowledge
of this trigger, asked a question regarding the benefit of an EMR in assisting with identifying
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when screening is needed. The survey also questioned if providers were screening for HCV if
they had defined risk factors. At the time the survey was administered, there were only three
providers practicing from the previous six. The PI believed the wording of the survey in
conjunction with the newly implemented EMR trigger may have created a barrier in provider
willingness to participate. The question was asked, “do you perform a one-time screening on all
patients born between 1945-1965,” may have been interpreted as if the provider was being
challenged regarding their individual screening practices. The question “do you feel patients are
adequately assessed for high risk behavior, specifically IVDU,” may also have been interpreted
as assessing individual provider practice. A greater number of responses may have been gained
if the question was asked, “what populations do you screen for HCV?” If the PI had known
about the emergence of the EMR trigger, the survey would have been administered prior to
implementing the trigger and after implementation.
Conclusion
The retrospective chart analysis assessed provider adherence to the current HCV
screening recommendations. Frequency distributions were analyzed to determine population
characteristics and HCV risk based screenings. Due to the high percentage of unscreened
subjects statistical analysis was not of value to determine significance. The larger focus was on
the birth cohort, as they represent approximately 70% of all HCV cases (CDC, 2013). The low
frequency of screening in this sample added to the evidence suggesting additional measures are
needed to prompt provider screenings (USPSTF, 2013). The 6.1% screening adherence that was
evaluated is much lower than a larger study completed in 2011, which found screening rates of
the birth cohort at 36.1 % (Southern et al., 2011). Due to having only one patient with HIV and
one with a history of IVDU in the study, it was difficult to determine if the providers would have
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been more inclined to screen if other risk factors were present. The patient that did admit to
IVDU but was never screened for HCV does provide insight that more provider education could
be beneficial to improve appropriate screenings. The patient with HIV told his provider that he
is monitored for HCV by his infectious disease provider.
The recommendations by multiple accredited agencies are conclusive in the need to
screen at risk patients for HCV to identify disease and reduce progression and transmission of a
now treatable infection (Aspinall et al., 2015). It will be of future value to evaluate cases of
HCV that have been diagnosed post EMR trigger to determine the significance of the
implementation. Going forward it would also be advisable to create a method of communicating
all new guidelines to providers to ensure they have been apprised of and have full understanding
of the content. Since efforts to improve birth cohort screenings have been addressed, future
studies could focus on the effectiveness of assessing additional HCV high risk groups. These
groups would include those having a history of blood transfusion or solid organ transplant before
1992, any history of IVDU, received clotting factor prior to 1987, long-term dialysis patients,
known blood exposure from patient known to have HCV, patients with lab work demonstrating
signs of liver disease, and any individual born to a HCV positive mother (CDC, 2014). While
persons with other risk factors contribute a smaller percentage of HCV cases, the total cost of the
disease from all factors is overwhelming. Any means to improve screening can affect the longterm consequences on the health care system as a whole, and on individual lives.
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Table 1.
Mean, Standard Deviation and Range for Continuous Variables: Evaluating Hepatitis C
Screening in Primary Care (N=100).
Variable

Mean

Standard

Actual Range

Potential Range

Deviation
Subject Age

60.5

6.8

36-71

18+
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Table 2.
Frequency Distributions for Selected Categorical Variables: Evaluating Hepatitis C Screening
in Primary Care (N=100).
Variable
Frequency/Percent (%)
Gender
Male
39
Female
61
Race
Caucasian
Black or African American
Hispanic
Unanswered

90
8
1
1

Born between 1945-1965
Yes
No

98
2

HIV Positive
Yes
No

1
99

History of IVDU
Yes
No
Unanswered

1
76
23

Screened for HCV
Yes
No

6
94

HCV positive
Yes
No

1
99
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Table 3.
2015 Practice Population Verses Sample Population Demographics; Subjects 18 years and
Older.
Practice population (4608)

Sample population (100)

Gender
Male
Female

45%
55%

39%
61%

Caucasian
African American
Hispanic
Other/Unanswered

85%
8%
<1%
6%

90%
8%
1%
1%

Born between 1945-1965

43%

98%

HIV Positive

.09%

1%

.1%

1%

Race

History of IVDU

